Alteogen Signs Licensing Deal With Biogen International For Alt-B4

Alteogen has signed a licensing deal with Biogen International for its Alt-B4 technology. This news, reported by Reuters, indicates a significant corporate development for Alteogen.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin